Chase Leavitt
Fortune : 40 200 $ au 30/06/2026
Fortune : 40 200 $ au 30/06/2026
Chase C.
Leavitt is currently Secretary & General Counsel at Oncternal Therapeutics, Inc. since 2022 and Secretary & General Counsel at Mobia Medical, Inc. starting in 2026.
Formerly, Mr. Leavitt was Secretary & General Counsel at Lineage Cell Therapeutics, Inc. from 2019 to 2021, Vice President-Legal Affairs at Tang Capital Management LLC from 2018 to 2019, Attorney at Latham & Watkins LLP from 2007 to 2014, Deputy General Counsel at Switch, Inc. from 2017 to 2018, and Vice President-Legal Affairs at Odonate, Inc. from 2018 to 2019.
Education includes undergraduate and graduate degrees from the University of Southern California, both conferred in 2007.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MOBIA MEDICAL, INC. 0,01 % | 11/05/2026 | 3 000 ( 0,01 % ) | 40 200 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ONCTERNAL THERAPEUTICS, INC. | Conseiller Juridique Général | 12/04/2021 |
| MOBIA MEDICAL, INC. | Conseiller Juridique Général | 01/02/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Conseiller Juridique Général | 29/03/2021 |
| ODONATE, INC. | Conseiller Juridique Général | 01/05/2019 |
Tang Capital Management LLC
Tang Capital Management LLC Investment ManagersFinance Tang Capital focuses on investments in small-cap US companies in the life sciences sector. | Conseiller Juridique Général | 01/05/2019 |
Switch, Inc.
Switch, Inc. Packaged SoftwareTechnology Services Develops job hunting mobile application | Corporate Officer/Principal | 01/05/2018 |
Latham & Watkins LLP
Latham & Watkins LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/01/2014 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 8 |
|---|---|
Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
Tang Capital Management LLC
Tang Capital Management LLC Investment ManagersFinance Tang Capital focuses on investments in small-cap US companies in the life sciences sector. | Finance |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Latham & Watkins LLP
Latham & Watkins LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
MicroTransponder, Inc.
MicroTransponder, Inc. Medical SpecialtiesHealth Technology Develops, markets and sells devices for treatment of neurological medical conditions | Health Technology |
Switch, Inc.
Switch, Inc. Packaged SoftwareTechnology Services Develops job hunting mobile application | Technology Services |
Odonate, Inc.
Odonate, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer treatment | Health Technology |
Oncternal Therapeutics, Inc.
Oncternal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that manufactures pharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national